FDA approves cellular gene therapy for refractory multiple myeloma Dr Satabdi Saha5 April 2021 5:23 AM GMTIn a recent development,FDA has given a nod to the first gene therapy for patients of relapsed or refractory multiple myeloma who have received at...
FDA approves new gene therapy for non-Hodgkin lymphomas Dr. Kamal Kant Kohli5 Feb 2021 10:32 PM GMTThe U.S. Food and Drug Administration has approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain ...
Scientists develop new gene therapy for deafness Dr. Kamal Kant Kohli18 Jan 2021 3:00 AM GMTResearchers atTel Aviv University (TAU) have presented an innovative treatment for deafness, based on the delivery of genetic material into the cells...
Gene therapy for reducing bleeding in hemophilia patients: HOPE B Trial Medha28 Dec 2020 12:30 PM GMTUSA: A recent study has shown the role of gene therapy in reducing bleeding rate among hemophilia patients. The findings of the study were presented...
Scientists develop new gene therapy for deafness Hina Zahid25 Dec 2020 3:53 PM GMTA new study from Tel Aviv University (TAU) presents an innovative treatment for deafness, based on the delivery of genetic material into the cells of...
Experimental therapy of One Eye may Improve vision in other in hereditary disease MD Bureau19 Dec 2020 1:45 PM GMTIn a recent trial (REVERSE) researchers have been able to improve vision in both eyes in a majority of patients with an inheritable condition called...
FDA Approves First Cell-Based Gene Therapy for Relapsed or Refractory MCL Hina Zahid26 July 2020 8:45 AM GMTThe U.S. Food and Drug Administration approved Tecartus (brexucabtagene autoleucel) for treatment of adult patients diagnosed with mantle cell...
Advancement made in Gene Therapy for x-Linked Retinitis Pigmentosa Dr. Kamal Kant Kohli2 March 2020 11:45 AM GMTRetinal gene therapy has shown great promise in treating retinitis pigmentosa (RP), a primary photoreceptor degeneration that leads to severe sight...
